Investor Presentaiton slide image

Investor Presentaiton

Adjusted EBITDA (twelve months ended) Twelve Months Ended ($ in thousands) Net income attributable to Albemarle Corporation Depreciation and amortization Non-recurring and other unusual items (excluding items associated with interest expense) Jun 30, 2021 Sep 30, 2021 Dec 31, 2021 Mar 31, 2022 Jun 30, 2022 703,213 212,131 $ 123,672 $ 281,378 263,551 244,132 247,535 254,000 258,314 267,884 (360,075) 291,102 481,194 478,490 885,605 Interest and financing expenses 89,413 75,322 61,476 45,428 79,685 Income tax expense 149,644 4,321 29,446 87,869 69,902 Non-operating pension and OPEB items 35,535 32,965 (78,814) (78,629) Adjusted EBITDA 861,862 863,376 870,974 $ 1,072,850 $ (78,196) 1,488,431 Net impact of adjusted EBITDA from divested businesses Adjusted EBITDA excluding impact from divested business $ (66,657) 795,205 (44,866) (28,415) (6,990) - $ 818,510 $ 842,559 $ 1,065,860 $ 1,488,431 Net sales $ 3,229,202 Net impact of net sales from divested business (162,290) 3,312,900 $ (120,095) Net sales excluding impact from divested business $ 3,066,912 3,192,805 3,327,957 (65,648) 3,262,309 3,626,394 4,332,091 (21,191) $ 3,605,203 $ 4,332,091 Adjusted EBITDA margin excluding impact from divested businesses 26 % 26 % 26 % 30% 34 % 44 MAKING THE WORLD SAFE AND SUSTAINABLE See above for a reconciliation of adjusted EBITDA and pro-forma adjusted EBITDA, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. See above for a reconciliation of pro-forma net sales, the non-GAAP financial measure, to net sales, the most directly comparable financial measure calculated and reported in accordance with GAAP. ALBEMARLE
View entire presentation